AXON ENTERPRISE, INC.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Notes to Consolidated Financial Statements
Note 1 –Organization and Summary of Significant Accounting Policies
Axon Enterprise, Inc. (“Axon”, the “Company”, “we”, or “us”) is a provider of public safety technology solutions. Our mission is to protect life in service of promoting peace, justice and strong institutions.
The accompanying unaudited consolidated financial statements include the accounts of Axon Enterprise, Inc. and our subsidiaries. All intercompany accounts, transactions and profits have been eliminated.
Basis of Presentation and Use of Estimates
These unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. Certain information related to our organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) has been condensed or omitted. The accounting policies followed in the preparation of these unaudited consolidated financial statements are consistent with those followed in our consolidated financial statements for the year ended December 31, 2025, as filed on our 2025 Annual Report on Form 10-K. In the opinion of management, these unaudited consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the financial statements included in our 2025 Annual Report on Form 10-K for the year ended December 31, 2025.
Our results of operations for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the full year (or any other period). The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. We believe the estimates used in the preparation of these unaudited consolidated financial statements are reasonable; however, actual results could differ materially from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist of accounts and notes receivable, contract assets and cash. Historically, we have experienced an immaterial level of write-offs related to uncollectible accounts. We hold the majority of our cash and cash equivalents accounts atthree depository institutions. As of June 30, 2026, the aggregate balances in such accounts were $0.5 billion. Our balances with these and other institutions regularly exceed Federal Deposit Insurance Corporation insured limits for domestic deposits and various deposit insurance programs in Australia, Canada, Germany, and the United Kingdom, among others. To manage the related credit exposure, management continually monitors the creditworthiness of the financial institutions where we have deposits.
Segment Information
As described further within our 2025 Annual Report on Form 10-K, we havetwo reportable segments: Connected Devices and Software and Services. Our chief operating decision maker (“CODM”) is our Chief Executive Officer. The segment measure of profit and loss is adjusted gross margin, as the CODM allocates resources and assesses performance based on review of adjusted gross margin by segment. Assets and other expense items, such as research and development and selling, general, and administrative expenses, are not provided to the CODM by segment, as our CODM does not evaluate our operating segments using this discrete information. For additional details, refer to Note 13.
Restricted Cash
Restricted cash balances were $11.9 million and $12.2 million as of June 30, 2026 and December 31, 2025, respectively. The restricted cash balance at June 30, 2026 includes a $9.7 million payment held in escrow related to the planned construction of our headquarters building in Arizona. Restricted cash also includes funds held in international bank accounts for various operating and financing activities.
Warranty Reserves
We warranty our conducted energy devices (“CEDs”), Axon cameras and other hardware on a limited basis for a period of primarilyone year after purchase. Changes in our estimated product warranty liabilities were as follows (in thousands):
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Balance, beginning of period | $10,858 | $8,284 |
| Utilization of reserve | (7,411) | (4,202) |
| Warranty expense | 6,855 | 6,794 |
| Balance, end of period | $10,302 | $10,876 |
Income per Common Share
Basic income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the periods presented. Diluted income per share reflects the potential dilution from outstanding stock-based awards, our 2027 Notes, and warrants to acquire shares of our common stock (the “Warrants” or “2027 Warrants”). These items are excluded from the computation of diluted net income per share in periods in which the effect would be antidilutive. For additional information regarding our 2027 Notes and 2027 Warrants, refer to Note 8.
The calculation of the weighted average number of shares outstanding and earnings per share is as follows (in thousands except per share data):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Numerator for basic and diluted earnings per share: | ||||
| Net income | $29,427 | $36,117 | $198,739 | $124,097 |
| Denominator: | ||||
| Weighted average shares outstanding | 80,573 | 77,999 | 80,363 | 77,448 |
| Dilutive effect of stock-based awards | 1,462 | 1,729 | 1,358 | 1,721 |
| Dilutive effect of 2027 Notes (1) | — | 820 | 47 | 1,210 |
| Dilutive effect of 2027 Warrants | 506 | 1,514 | 750 | 1,403 |
| Diluted weighted average shares outstanding | 82,541 | 82,062 | 82,518 | 81,782 |
| Net income per common share: | ||||
| Basic | $0.37 | $0.46 | $2.47 | $1.60 |
| Diluted | $0.36 | $0.44 | $2.41 | $1.52 |
(1)We redeemed all of our remaining outstanding 2027 Notes during the three months ended March 31, 2026, and we repurchased a portion of the 2027 Notes during the three months ended March 31, 2025. Accordingly, the dilutive impact to the six months ended June 30, 2026 and June 30, 2025 related to the 2027 Notes is weighted for (a) the number of days between the beginning of the period and the respective closing dates of each transaction, which includes the total amount of shares issuable upon a conversion of all of the 2027 Notes outstanding as of the beginning of the respective periods, and (b) subsequent to the respective closing dates, which includes the amount of shares issuable upon a conversion of the 2027 Notes that remain after each respective transaction. No 2027 Notes remained outstanding following settlement of the aforementioned redemption. Refer to Note 8 for additional details.
Potentially dilutive securi ties that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Stock-based awards | 3,277 | 3,854 | 3,237 | 3,871 |
| 2027 Notes | — | 415 | — | 429 |
| 2027 Warrants | 2,156 | 1,503 | 1,912 | 1,614 |
| Total potentially dilutive securities | 5,433 | 5,772 | 5,149 | 5,914 |
Accounting Guidance and Disclosure Rules - Recently Adopted
In September 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025‑06, Intangibles - Goodwill and Other - Internal‑Use Software (Sub-topic 350-40): Targeted Improvements to the Accounting for Internal‑Use Software. ASU 2025‑06 is intended to modernize the internal‑usesoftware model primarily by removing software development stages and introducing a “probable-to-complete recognition threshold.” The provisions of ASU 2025-06 are effective for our Annual Report on Form 10-K for the year ending December 31, 2026. We elected to early adopt this ASU in the first quarter of 2026 on a fully prospective basis. The adoption of this standard did not result in any material impacts to our consolidated financial statements.
In July 2025, the FASB issued ASU 2025‑05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. ASU 2025‑05 is intended to provide a practical expedient for estimating expected credit losses on current trade receivables and current contract assets. The provisions of ASU 2025‑05 are effective for annual periods beginning after December 15, 2025. We adopted this standard in the first quarter of 2026. The adoption of this standard did not result in any material impacts to our consolidated financial statements.
Accounting Guidance and Disclosure Rules - Not Yet Adopted
Refer to Note 1 to the consolidated financial statements in our 2025 Annual Report on Form 10-K for a discussion of applicable standards issued and not yet adopted. Relevant new unadopted standards issued subsequent to our most recent Annual Report are included below.
In May 2026, the FASB issued ASU 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818). ASU 2026-02 establishes recognition, measurement, presentation, and disclosure requirements for environmental credits and environmental credit obligations. The provisions of ASU 2026-02 are effective for our Quarterly Report on Form 10-Q for the quarter ending March 31, 2028 and subsequent interim and annual periods thereafter, with early adoption permitted. We are currently evaluating the impact of this update on our consolidated financial statements.
Note 2 –Revenues
Nature of Products and Services
The following table presents our revenues by primary product and service offering and reportable segment (in thousands):
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | |||||
|---|---|---|---|---|---|---|
| Connected Devices | Software and Services | Total | Connected Devices | Software and Services | Total | |
| TASER (1) | $261,321 | $— | $261,321 | $216,234 | $— | $216,234 |
| Personal Sensors (2) | 95,392 | — | 95,392 | 92,819 | — | 92,819 |
| Platform Solutions (3) | 149,840 | — | 149,840 | 67,307 | — | 67,307 |
| Software and Services | — | 397,836 | 397,836 | — | 292,178 | 292,178 |
| Total | $506,553 | $397,836 | $904,389 | $376,360 | $292,178 | $668,538 |
| Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | |||||
|---|---|---|---|---|---|---|
| Connected Devices | Software and Services | Total | Connected Devices | Software and Services | Total | |
| TASER (1) | $494,174 | $— | $494,174 | $411,729 | $— | $411,729 |
| Personal Sensors (2) | 204,143 | — | 204,143 | 181,224 | — | 181,224 |
| Platform Solutions (3) | 261,057 | — | 261,057 | 124,303 | — | 124,303 |
| Software and Services | — | 752,360 | 752,360 | — | 554,915 | 554,915 |
| Total | $959,374 | $752,360 | $1,711,734 | $717,256 | $554,915 | $1,272,171 |
| Three Months Ended June 30, · Six Months Ended June 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2026 · 2025 · 2026 · 2025 | ||||||||
| United States | $742,307 | 82% | $537,373 | 80% | $1,388,834 | 81% | $1,066,756 | 84% |
| Other countries | 162,082 | 18 | 131,165 | 20 | 322,900 | 19 | 205,415 | 16 |
| Total | $904,389 | 100% | $668,538 | 100% | $1,711,734 | 100% | $1,272,171 | 100% |
Revenue Recognized from Contract Liabilities
During the six months ended June 30, 2026 and 2025, we recognized revenue of $524.8 million and $456.2 million, respectively, from our beginning contract liabilities balance as of December 31, 2025 and 2024, respectively. Refer to our consolidated balance sheets for additional details regarding our receivables, contract assets and contract liabilities from contracts with customers.
Remaining Performance Obligations
As of June 30, 2026, we had approximately $9.8 billion of remaining performance obligations, which included both recognized contract liabilities as well as amounts that will be invoiced and recognized in future periods. The remaining performance obligations are limited only to arrangements that meet the definition of a contract under ASC 606 as of June 30, 2026. We currently expect to recognize approximately 20% -25% of this balance over the next 12 months, and expect the remainder to be substantially recognized over the followingten years, subject to risks related to delayed deployments, budget appropriation or other contract cancellation clauses.
Note 3 –Cash, Cash Equivalents and Investments
The following tables summarize our cash, cash equivalents, marketable securities and available-for-sale debt investments at June 30, 2026 and December 31, 2025 (in thousands):
| As of June 30, 2026 | |||||||
|---|---|---|---|---|---|---|---|
| AmortizedCost | GrossUnrealizedGains | GrossUnrealizedLosses | Fair Value | Cash andCashEquivalents | Marketable Securities | Short-TermInvestments | |
| Cash | $262,275 | $— | $— | $262,275 | $262,275 | $— | $— |
| Level 1: | |||||||
| Money market funds | 293,215 | — | — | 293,215 | 293,215 | — | — |
| Marketable securities | 13,100 | 6,026 | — | 19,126 | — | 19,126 | — |
| Subtotal | 306,315 | 6,026 | — | 312,341 | 293,215 | 19,126 | — |
| Level 2: | |||||||
| Term deposits | 117,917 | — | — | 117,917 | 42,214 | — | 75,703 |
| Subtotal | 117,917 | — | — | 117,917 | 42,214 | — | 75,703 |
| Total | $686,507 | $6,026 | $— | $692,533 | $597,704 | $19,126 | $75,703 |
During the six months ended June 30, 2026, proceeds from the sale of available-for-sale securities were$70.5 million. As of June 30, 2026, we heldno available-for-sale debt investments with unrealized losses.
During thesix months ended June 30, 2026, net proceeds from the sales of marketable securities were$3.7 million, representing net realized gains of $1.7 million from the time of purchase. During thethree and six months ended June 30, 2026, we recorded an unrealized gain of$1.1 million and loss of$4.5 millionon marketable securities still held as of the reporting date, respectively. We recorded unrealized losses on marketable securities of $30.9 million and $54.3 million, respectively, for the same periods in the prior year.
| As of December 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| AmortizedCost | GrossUnrealizedGains | GrossUnrealizedLosses | Fair Value | Cash andCashEquivalents | Marketable Securities | Short-TermInvestments | |
| Cash | $168,294 | $— | $— | $168,294 | $168,294 | $— | $— |
| Level 1: | |||||||
| Money market funds | 821,711 | — | — | 821,711 | 821,711 | — | — |
| Marketable securities | 15,093 | 12,120 | — | 27,213 | — | 27,213 | — |
| U.S. Treasury bills | 231,766 | 69 | — | 231,835 | 200,200 | — | 31,635 |
| Agency bonds | 6,456 | 3 | — | 6,459 | — | — | 6,459 |
| Subtotal | 1,075,026 | 12,192 | — | 1,087,218 | 1,021,911 | 27,213 | 38,094 |
| Level 2: | |||||||
| Term deposits | 385,942 | — | — | 385,942 | 10,942 | — | 375,000 |
| Corporate bonds | 72,322 | 42 | (3) | 72,361 | — | — | 72,361 |
| Commercial paper | 18,462 | — | — | 18,462 | — | — | 18,462 |
| Certificates of deposit | 1,500 | — | — | 1,500 | — | — | 1,500 |
| Subtotal | 478,226 | 42 | (3) | 478,265 | 10,942 | — | 467,323 |
| Total | $1,721,546 | $12,234 | $(3) | $1,733,777 | $1,201,147 | $27,213 | $505,417 |
As of December 31, 2025, we had $9.7 millionof available-for-sale investments with unrealized losses, of which none have been in a continuous unrealized loss position for 12 months or longer. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases.
Note 4 –Inventory
Inventory consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Raw materials | $214,857 | $152,680 |
| Work-in-process | 13,537 | 8,866 |
| Finished goods | 258,162 | 180,265 |
| Total inventory | $486,556 | $341,811 |
Note 5 –Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for thesix months ended June 30, 2026 were as follows (in thousands):
| Connected Devices | Software andServices | Total | |
|---|---|---|---|
| Balance, beginning of period | $51,249 | $1,318,940 | $1,370,189 |
| Goodwill acquired | 4,581 | 524,733 | 529,314 |
| Purchase accounting adjustments | — | 63 | 63 |
| Foreign currency translation adjustments | (114) | (625) | (739) |
| Balance, end of period | $55,716 | $1,843,111 | $1,898,827 |
Intangible assets (other than goodwill) consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):
| June 30, 2026 · December 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| UsefulLife | GrossCarryingAmount | AccumulatedAmortization | NetCarryingAmount | GrossCarryingAmount | AccumulatedAmortization | NetCarryingAmount | |
| Amortizable (definite-lived) intangible assets: | |||||||
| Developed technology | 3 ‑ 8 years | $262,122 | $(63,653) | $198,469 | $183,122 | $(44,399) | $138,723 |
| Customer relationships | 5 ‑ 10 years | 68,231 | (12,748) | 55,483 | 41,329 | (8,960) | 32,369 |
| Issued trademarks | 3 ‑ 23 years | 11,986 | (5,377) | 6,609 | 9,900 | (3,856) | 6,044 |
| Issued patents | 8 ‑ 26 years | 3,002 | (1,641) | 1,361 | 3,017 | (1,602) | 1,415 |
| Domain names | 5 ‑ 10 years | 4,568 | (2,968) | 1,600 | 3,043 | (2,738) | 305 |
| Total amortizable | 349,909 | (86,387) | 263,522 | 240,411 | (61,555) | 178,856 | |
| Non-amortizable (indefinite-lived) intangible assets: | |||||||
| In-process research and development (1) | 16,600 | — | 16,600 | 16,600 | — | 16,600 | |
| Trademarks | 1,068 | — | 1,068 | 1,068 | — | 1,068 | |
| Patents and trademarks pending | 393 | — | 393 | 448 | — | 448 | |
| Total non-amortizable | 18,061 | — | 18,061 | 18,116 | — | 18,116 | |
| Total intangible assets | $367,970 | $(86,387) | $281,583 | $258,527 | $(61,555) | $196,972 | |
(1)During the six months ended June 30, 2026, no in-process research and development costs were placed into service. During the six months ended June 30, 2025, approximately $15.3 million has been placed into service.
Amortization expense of intangible assets for the three and six months ended June 30, 2026 was $13.4 million and $24.9 million, respectively. Amortization expense of intangible assets for the three and six months ended June 30, 2025 was $6.7 million and $13.3 million, respectively. Estimated amortization for intangible assets with definite lives for the remaining six months of 2026, the next five years ended December 31, and thereafter, is as follows (in thousands):
| 2026 remaining | $26,872 |
| 2027 | 52,521 |
| 2028 | 50,289 |
| 2029 | 47,336 |
| 2030 | 35,726 |
| 2031 | 18,341 |
| Thereafter | 32,437 |
| Total | $263,522 |
Note 6 –Strategic Investments
During the six months ended June 30, 2026, we closed a series of transactions to acquire additional equity interests in an existing strategic investee for an aggregate amount of $189.8 million. We also recognized a gain of $158.8 million related to an observable price change for existing investments in the same strategic investee. During the six months ended June 30, 2026, we also acquired equity interests in a separate strategic investee for an aggregate amount of $49.9 million.
During the six months ended June 30, 2025, we closed a series of transactions to acquire additional equity interests in an existing strategic investee for an aggregate amount of $215.1 million. We also recognized a gain of $167.4 million related to an observable price change of a separate existing strategic investee. Furthermore, we entered into a series of transactions to sell certain interests for cash consideration of $340.7 million in the same strategic investee, which was received during the six months ended June 30, 2025. Previously unrealized gains of $320.8 million were realized from the collective sales, net of $1.3 million of transaction costs.
The following table presents the carrying value of our strategic investments at June 30, 2026 and December 31, 2025 (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Equity securities: | ||
| Non-marketable equity securities (1) | $848,099 | $416,236 |
| Debt securities: | ||
| Non-marketable debt securities | 5,743 | 597 |
| Total strategic investments | $853,842 | $416,833 |
(1)As of June 30, 2026 and December 31, 2025, the carrying value of our strategic investments held under the equity method of accounting was $24.5 million and $1.6 million, respectively.
The life to date cumulative upward and downward adjustments to the carrying value of our strategic equity investments accounted for under the ASC 321 measurement alternative and still held as of June 30, 2026 were $176.0 million and $15.4 million, respectively.
As of June 30, 2026 and December 31, 2025, the carrying value of our variable interest assets in unconsolidated non-public variable interest entities was $126.1 million and $9.4 million, respectively. These balances reflect the maximum exposure to loss, which is limited to the carrying value of the interest.
The following table summarizes the gains andlosses associated with our strategic investments during the three and six months ended June 30, 2026 and 2025 (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Realized gains recognized on strategic investments during the period, net | $240 | $47,339 | $37,971 | $320,817 |
| Reversal of prior period cumulative unrealized (gains) losses, net, for securities sold during the period | — | (47,339) | — | (160,736) |
| Unrealized gains on strategic investments still held at the reporting date (1) | 5,566 | 751 | 164,435 | 7,991 |
| Unrealized losses, including impairments, on strategic investments still held at the reporting date (1) | (97) | (2,048) | (97) | (2,048) |
| Income (loss) from strategic investments, net | $5,709 | $(1,297) | $202,309 | $166,024 |
(1)Includes immaterial income (losses) from strategic investments held under the equity method of accounting, as well as immaterial unrealized gains (losses) for debt security strategic investments.
Note 7 –Accrued Liabilities
Accrued liabilities consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Accrued commissions | $85,240 | $150,811 |
| Accrued third-party product costs | 69,022 | 73,497 |
| Accrued salaries and benefits | 34,189 | 35,251 |
| Accrued income and other taxes | 33,011 | 27,339 |
| Accrued professional and IT fees | 32,578 | 24,359 |
| Accrued bonus | 32,435 | 78,403 |
| Accrued interest | 31,837 | 31,855 |
| Accrued inventory in transit | 25,648 | 15,728 |
| Accrued cloud hosting fees | 15,380 | 14,049 |
| Accrued warranty expense | 10,302 | 10,858 |
| Other accrued expenses | 54,290 | 48,388 |
| Total accrued liabilities | $423,932 | $510,538 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.